HomeRLMD • NASDAQ
add
Relmada Therapeutics Inc
Previous close
$0.82
Day range
$0.80 - $0.90
Year range
$0.24 - $4.47
Market cap
27.03M USD
Avg Volume
1.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.22M | -20.75% |
Net income | -17.56M | 19.56% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 27.06M | -67.64% |
Total assets | 27.68M | -67.21% |
Total liabilities | 5.24M | -57.62% |
Total equity | 22.44M | — |
Shares outstanding | 33.19M | — |
Price to book | 1.21 | — |
Return on assets | -123.94% | — |
Return on capital | -157.16% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -17.56M | 19.56% |
Cash from operations | -18.07M | -38.59% |
Cash from investing | 15.36M | 52.70% |
Cash from financing | — | — |
Net change in cash | -2.71M | 1.79% |
Free cash flow | -11.68M | -113.42% |
About
Founded
2004
Headquarters
Website
Employees
17
